Skip to content

The effects of Transcranial Direct Current Stimulation on Craving and Response Inhibition in Internet Gaming Disorder

Evaluation of efficacy and safety of YDS-301N (Transcranial direct current stimulation) for controlling of craving in patients with Internet gaming disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009220
Enrollment
118
Registered
2024-03-06
Start date
2018-03-25
Completion date
Unknown
Last updated
2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Randomized, double-blind, and sham-controlled clinical trial 1. Active tDCS 1) applied daily on weekdays (5 sessions per week) for a total of 10 active sessions over two weeks 2) e
induced a skin sensation similar to active stimulation

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Males aged 19 years and older but less than 39 years 2. Primary satisfaction of the diagnostic criteria for Internet gaming disorder as outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 3. Young's Internet Addiction Test (Y-IAT) score of 40 or above 4. Willing participants who voluntarily consent to all examinations and test according to the research protocol

Exclusion criteria

Exclusion criteria: 1. Individuals diagnosed with or suspected of having Axis I disorders other than Internet gaming disorder 2. Individuals receiving other treatments (such as medication or psychotherapy) for Internet gaming disorder 3. Individuals with scalp abnormalities, inflammatory reactions, or other dermatological issues that may pose problems for tDCS electrode attachment 4. Individuals deemed ineligible due to other prohibited reasons for the use of tDCS medical devices (e.g., presence of metal plates inserted into the skull) 5. Individuals with uncontrollable major medical or neurological diseases 6. Individuals with localized neurological symptoms and signs, including seizure disorders 7. Individuals with a medical history of side effects related to various radiopharmaceuticals, including contrast agents 8. Individuals with a history of brain surgery or insertion of magnetic substances into the head or eyes 9. Individuals with implanted devices such as artificial pacemakers, drug infusion pumps, or hearing aids 10. Additionally, individuals for whom the principal investigator or responsible party has medically determined that they are clinically inappropriate for this trial for reasons beyond those listed above

Design outcomes

Primary

MeasureTime frame
Craving visual analog scale (0-10);stop-signal reaction time and stop trial errors in Stop-signal task

Secondary

MeasureTime frame
Seed-based functional connectivity in functional MRI (seeds: bilateral dorsolateral prefrontal cortex, nuclues accumbens)

Countries

Korea, Republic of

Contacts

Public ContactJo-Eun Jeong

The Catholic University of Korea, Daejeon St. Mary's Hospital

goodi11@hanmail.net+82-42-220-9020

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026